Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of Dysport RU versus Dysport and placebo in cervical dystonia
2010-019907-43Phase 3Completed
- Sponsor
- Ipsen
- Start
- Dec 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of botulinum toxin type A in cervical dystonia (CD) (3 arms), sponsored by Ipsen. Started Dec 2010; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on 2010-019907-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019907-43.